Perlara, PBC is a biotech startup in San Francisco, discovering small molecule therapeutics for orphan diseases. We utilize model organisms (S. cerevisiae, C. elegans and D. melanogaster) in phenotypic screens to identify therapeutic candidates for rare genetic diseases. We are seeking candidates for the following:

Research Associate II – C. elegans Assay Development

Research Associate – Drosophila Assay Development


Startup Life from our Blog

Funding announcement

This week we announced a $7.4M equity financing. Endpoints News and STAT News covered the announcement and the Twitter angle. Here’s the backstory from the CEO's vantage point. From the outside, this round appears to be our Series A. But it’s technically our Series B...

read more

Midsummer updates

Perlara midsummer 2017 updates—We took a temporary hiatus from blogging starting in March right after my Rare Disease Day post. The reason: fundraising. Raising money is personally all-consuming for the CEO, as I'll attest in an upcoming post. It's also a persistent...

read more

Perlara logo 300x108px

Join our mailing list

Translate »